HTG Molecular Diagnostics Inc (STU:65H)
€ 0.242 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q4 2019 HTG Molecular Diagnostics Inc Earnings Call Transcript

Mar 25, 2020 / 08:30PM GMT
Release Date Price: €53.28 (-1.99%)
Operator

Good afternoon, and welcome to HTG Molecular Diagnostics Year-end Earnings Conference Call. My name is Devin, and I will be your coordinator for the call today. (Operator Instructions) As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Monique Kosse from LifeSci Advisors for a few introductory comments. Thank you. You may begin.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, operator. Earlier today, HTG released financial results for the year ended December 31, 2019.

Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws, including statements regarding possible additional collaborations with pharma customers, anticipated continued growth in RUO profiling business and related revenue, expected growth in and benefits from pharma programs and collaborations, product development and commercialization activity. These forward-looking statements are subject to numerous risks and uncertainties, many

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot